A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies

NCT05379634 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Myositis

Interventions

DRUG: Nipocalimab
OTHER: Placebo
DRUG: Glucocorticoids

Sponsor

Janssen Research & Development, LLC